Understanding how advanced pancreatic cancer patients respond to chemotherapy

This is a registry study—meaning researchers are collecting information from patients with advanced pancreatic cancer to understand how different chemotherapy treatments work in real-world settings. Instead of testing a brand-new drug, the study gathers data from patients already receiving standard chemotherapy (such as platinum-based or gemcitabine-based treatments) to learn what works best and why outcomes differ from person to person.

Pancreatic cancer is a serious disease, and doctors need better information about which chemotherapy approaches help patients most. By collecting data from many patients across Austria, researchers hope to identify patterns that could improve how the disease is treated in the future.